A phase 1b trial of prexasertib in combination with chemoradiation in patients with locally advanced head and neck squamous cell carcinoma (HNSCC)

被引：0
|
作者：
Yang, E. S. [1 ]
Deutsch, E. [2 ]
Mehmet, A. [3 ]
Fayette, J. [4 ]
Nabell, L. [5 ]
Spencer, S. A. [1 ]
Dobelbower, M. C. [1 ]
Willey, C. D. [1 ]
Bonner, J. A. [1 ]
Wang, X. [6 ]
Lin, A. [6 ]
William, W. N. [7 ]
机构：
[1] Univ Alabama Birmingham, Birmingham, AL USA
[2] Univ Paris Saclay, Gustave Roussy, Villejuif, France
[3] MD Anderson, Houston, TX USA
[4] Univ Lyon, Ctr Leon Berard, Ctr Canc, Clin Oncol, Lyon, France
[5] Univ Alabama Birmingham, Ctr Comprehens Canc, Clin Studies Unit, Birmingham, AL 35294 USA
[6] Eli Lilly & Co, Indianapolis, IN 46285 USA
[7] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2020年 / 106卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
201
引用
收藏
页码：1136 / 1136
页数：1
相关论文
共 50 条
  • [31] A phase 1b/2 trial of lenvatinib plus pembrolizumab in patients with squamous cell carcinoma of the head and neck.
    Taylor, Matthew H.
    Rasco, Drew W.
    Brose, Marcia S.
    Vogelzang, Nicholas J.
    Richey, Stephen Lane
    Cohn, Allen Lee
    Richards, Donald A.
    Stepan, Daniel E.
    Dutcus, Corina E.
    Guo, Matthew
    Shumaker, Robert Charles
    Schmidt, Emmett V.
    Wirth, Lori J.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [32] Phase I trial of chemoradiotherapy with the combination of S-1 plus cisplatin for patients with unresectable locally advanced squamous cell carcinoma of the head and neck
    Tahara, Makoto
    Minami, Hironobu
    Kawashima, Mitsuhiko
    Kawada, Kenji
    Mukai, Hirofumi
    Sakuraba, Minoru
    Matsuura, Kazuto
    Ogino, Takashi
    Hayashi, Ryuichi
    Ohtsu, Atsushi
    [J]. CANCER SCIENCE, 2011, 102 (02) : 419 - 424
  • [33] Phase 1b trial of cabozantinib in combination with atezolizumab in patients with locally advanced or metastatic urothelial carcinoma or renal cell carcinoma
    Maia, Manuel Caitano
    Agarwal, Neeraj
    McGregor, Bradley
    Vaishampayan, Ulka
    Choueiri, Toni K.
    Green, Marjorie
    Hessel, Colin
    Scheffold, Christian
    Schwab, Gisela
    Powles, Thomas
    Pal, Sumanta
    [J]. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2017, 5
  • [34] Concurrent chemoradiation therapy for advanced head and neck squamous cell carcinoma (HNSCC) in a community hospital.
    Levine, MA
    Saunders, JR
    Zinreich, E
    Kunar, D
    Price, J
    Hirata, RM
    Williams, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 502S - 502S
  • [35] Effects of prexasertib, a CHK1 inhibitor, in the immune microenvironment of head and neck squamous cell carcinoma (HNSCC).
    Chaudhary, Ritu
    Slebos, Robbert
    Song, Feifei
    McCleary-Sharpe, Keegan
    Masannat, Jude
    Tan, Aik Choon
    Wang, Xuefeng
    Amaladas, Nelusha
    Wu, Wenjuan
    Hall, Gerald
    Chung, Christine H.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [36] Results of salvage neck dissection after chemoradiation in locally advanced head and neck squamous cell carcinoma
    L. López
    P. García-Cabo
    J. L. Llorente
    F. López
    J. P. Rodrigo
    [J]. European Archives of Oto-Rhino-Laryngology, 2024, 281 : 945 - 951
  • [37] Results of salvage neck dissection after chemoradiation in locally advanced head and neck squamous cell carcinoma
    Lopez, L.
    Garcia-Cabo, P.
    Llorente, J. L.
    Lopez, F.
    Rodrigo, J. P.
    [J]. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2024, 281 (02) : 945 - 951
  • [38] Durvalumab with cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: A phase 1/2 trial
    Bonomo, Pierluigi
    Desideri, Isacco
    Mangoni, Monica
    Saieva, Calogero
    Loi, Mauro
    Becherini, Carlotta
    Cerbai, Cecilia
    Ganovelli, Michele
    Salvestrini, Viola
    Stocchi, Giulia
    Zani, Margherita
    Palomba, Annarita
    Livi, Lorenzo
    [J]. RADIOTHERAPY AND ONCOLOGY, 2022, 169 : 64 - 70
  • [39] Response of chemoradiation therapy after induction chemotherapy failure in locally advanced head and neck squamous cell carcinoma (LA-HNSCC).
    Lim, Yoojoo
    Keam, Bhumsuk
    Koh, Youngil
    Lee, Kyung-Hun
    Kim, Tae Min
    Lee, Se-Hoon
    Hah, Jeong-Hun
    Kwon, Tack-Kyun
    Kim, Dong-Wan
    Wu, Hong-Gyun
    Sung, Myung-Whun
    Heo, Dae Seog
    Kim, Kwang Hyun
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [40] Factors associated with hospitalization in patients (pts) with locally advanced squamous cell carcinoma of the head and neck (LA-HNSCC) treated with definitive chemoradiation (CRT).
    Park, Soo J.
    Parikh, Mili
    Harrington, Joanne
    Heppner, Pia
    McCarthy, Kelly
    Crandall, Bailey
    Wong-Sefidan, Ida
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
12345